Calix (CALX) Financials

$41.98 -0.02 (-0.05%)

Closing price 05/5/2025 03:59 PM Eastern

Extended Trading

$41.60 -0.38 (-0.91%)

As of 07:04 AM Eastern

Annual Income Statements for Calix

This table shows Calix's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-26	-27	-83	-19	-18	33	238	41	29	-30
Consolidated Net Income / (Loss)	-26	-27	-83	-19	-18	33	238	41	29	-30
Net Income / (Loss) Continuing Operations	-26	-27	-83	-19	-18	33	238	41	29	-30
Total Pre-Tax Income	-26	-27	-82	-19	-17	34	73	54	35	-32
Total Operating Income	-27	-28	-82	-19	-15	37	74	53	26	-43
Total Gross Profit	190	201	173	197	188	267	357	435	518	454
Total Revenue	407	459	510	441	424	541	679	868	1,040	832
Operating Revenue	407	459	510	441	424	541	679	868	1,040	832
Total Cost of Revenue	217	258	337	244	236	274	323	432	521	378
Operating Cost of Revenue	217	258	337	244	236	274	323	432	521	378
Total Operating Expenses	217	229	254	216	203	230	283	383	493	497
Selling, General & Admin Expense	38	42	40	41	37	44	56	76	100	99
Marketing Expense	79	84	83	86	83	94	126	175	215	218
Research & Development Expense	90	107	128	90	81	85	102	132	178	180
Total Other Income / (Expense), net	0.71	1.06	-0.23	-0.25	-1.13	-2.56	-1.28	1.43	9.17	11
Interest & Investment Income	0.14	0.15	-0.16	-0.63	-0.96	-1.59	-0.40	2.01	9.70	12
Other Income / (Expense), net	0.57	0.91	-0.07	0.38	-0.17	-0.98	-0.88	-0.58	-0.53	-0.96
Income Tax Expense	0.54	0.35	1.24	0.53	1.16	0.80	-166	13	5.43	-1.90
Basic Earnings per Share	($0.51)	($0.56)	($1.66)	($0.37)	($0.32)	$0.57	$3.77	$0.63	$0.44	($0.45)
Weighted Average Basic Shares Outstanding	51.49M	48.73M	50.16M	52.61M	54.99M	59.07M	63.28M	65.06M	65.98M	65.88M
Diluted Earnings per Share	($0.51)	($0.56)	($1.66)	($0.37)	($0.32)	$0.54	$3.51	$0.60	$0.42	($0.45)
Weighted Average Diluted Shares Outstanding	51.49M	48.73M	50.16M	52.61M	54.99M	62.00M	67.86M	68.91M	69.32M	65.88M
Weighted Average Basic & Diluted Shares Outstanding	51.49M	48.73M	50.16M	52.61M	54.99M	62.45M	64.44M	66.14M	65.41M	66.69M
Cash Dividends to Common per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	-	$0.00	$0.00

This table shows Calix's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025
Net Income / (Loss) Attributable to Common Shareholders	13	12	9.60	9.37	17	-6.60	0.10	-7.96	-3.97	-18	-4.79
Consolidated Net Income / (Loss)	13	12	9.60	9.37	17	-6.60	0.10	-7.96	-3.97	-18	-4.79
Net Income / (Loss) Continuing Operations	13	12	9.60	9.37	17	-6.60	0.10	-7.96	-3.97	-18	-4.79
Total Pre-Tax Income	20	14	11	14	18	-9.02	0.47	-8.68	-7.79	-16	-2.99
Total Operating Income	20	13	9.94	12	16	-12	-2.03	-11	-11	-19	-6.08
Total Gross Profit	119	125	128	136	141	113	123	108	110	113	123
Total Revenue	236	245	250	261	264	265	226	198	201	206	220
Operating Revenue	236	245	250	261	264	265	226	198	201	206	220
Total Cost of Revenue	118	120	122	125	123	151	104	91	91	93	98
Operating Cost of Revenue	118	120	122	125	123	151	104	91	91	93	98
Total Operating Expenses	99	112	118	125	125	125	125	119	121	132	129
Selling, General & Admin Expense	19	22	23	25	25	27	26	23	23	27	27
Marketing Expense	46	51	52	55	52	56	54	52	52	59	58
Research & Development Expense	33	39	43	45	47	42	44	44	45	46	44
Total Other Income / (Expense), net	0.46	0.97	1.47	2.42	2.21	3.07	2.50	2.67	3.10	3.11	3.09
Interest & Investment Income	0.60	1.14	1.64	2.26	2.66	3.15	2.64	2.96	3.28	3.47	3.29
Other Income / (Expense), net	-0.13	-	-0.17	0.16	-0.44	-0.08	-0.14	-0.29	-0.18	-0.36	-0.20
Income Tax Expense	7.02	2.16	1.81	4.86	1.19	-2.43	0.37	-0.72	-3.82	2.28	1.80
Basic Earnings per Share	$0.21	$0.17	$0.15	$0.14	$0.26	($0.11)	$0.00	($0.12)	($0.06)	($0.27)	($0.07)
Weighted Average Basic Shares Outstanding	65.36M	65.06M	66.04M	66.27M	66.29M	65.98M	65.34M	65.68M	66.08M	65.88M	66.03M
Diluted Earnings per Share	$0.19	$0.18	$0.14	$0.13	$0.24	($0.09)	$0.00	($0.12)	($0.06)	($0.27)	($0.07)
Weighted Average Diluted Shares Outstanding	69.17M	68.91M	69.71M	69.66M	69.58M	69.32M	68.12M	65.68M	66.08M	65.88M	66.03M
Weighted Average Basic & Diluted Shares Outstanding	65.44M	66.14M	66.24M	66.32M	65.87M	65.41M	65.53M	65.80M	66.32M	66.69M	64.82M

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-25	27	-11	10	-2.82	33	-29	28	-16	-20
Net Cash From Operating Activities	-5.34	24	-63	3.56	4.65	51	57	27	56	68
Net Cash From Continuing Operating Activities	-5.34	24	-63	3.56	4.65	51	57	27	56	68
Net Income / (Loss) Continuing Operations	-26	-27	-83	-19	-18	33	238	41	29	-30
Consolidated Net Income / (Loss)	-26	-27	-83	-19	-18	33	238	41	29	-30
Depreciation Expense	10	8.32	11	9.19	10	14	15	14	17	20
Amortization Expense	19	6.19	-	-	-	0.00	0.00	-1.15	-4.20	-5.29
Non-Cash Adjustments To Reconcile Net Income	14	14	13	11	14	18	24	45	63	71
Changes in Operating Assets and Liabilities, net	-23	23	-3.38	2.58	-1.79	-14	-221	-72	-48	13
Net Cash From Investing Activities	4.67	12	20	-0.08	-13	-61	-111	-24	-6.25	-110
Net Cash From Continuing Investing Activities	4.67	12	20	-0.08	-13	-61	-111	-24	-6.25	-110
Purchase of Property, Plant & Equipment	-7.28	-9.84	-8.03	-10	-13	-7.82	-10	-14	-18	-18
Purchase of Investments	-60	-16	-8.73	0.00	0.00	-73	-298	-191	-216	-302
Sale and/or Maturity of Investments	72	38	36	0.00	0.00	20	198	181	228	210
Net Cash From Financing Activities	-24	-9.24	32	7.49	5.97	42	24	25	-66	21
Net Cash From Continuing Financing Activities	-24	-9.24	32	7.49	5.97	42	24	25	-66	21
Repurchase of Common Equity	-27	-13	-	-	-	-	0.00	0.00	-86	-11
Other Financing Activities, net	-1.71	-2.08	-2.70	0.31	5.97	12	24	25	20	32
Other Net Changes in Cash	-	-	-	-0.48	-	-	-	-	-	-0.01
Cash Interest Paid	0.13	0.13	0.31	0.65	1.12	1.69	0.63	0.58	0.25	0.00
Cash Income Taxes Paid	0.48	0.97	0.92	0.56	0.40	0.75	5.20	9.61	12	5.88

This table details how cash moves in and out of Calix's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025
Net Change in Cash & Equivalents	24	3.90	15	-4.00	45	-72	25	-3.93	-22	-19	-0.86
Net Cash From Operating Activities	6.71	6.11	8.11	17	16	15	15	22	16	15	17
Net Cash From Continuing Operating Activities	6.71	6.11	8.11	17	16	15	15	22	16	15	17
Net Income / (Loss) Continuing Operations	13	12	9.60	9.37	17	-6.60	0.10	-7.96	-3.97	-18	-4.79
Consolidated Net Income / (Loss)	13	12	9.60	9.37	17	-6.60	0.10	-7.96	-3.97	-18	-4.79
Depreciation Expense	3.17	3.48	3.72	4.19	4.27	4.45	4.87	5.12	4.82	4.75	4.27
Amortization Expense	-0.53	-0.61	-0.71	-1.19	-1.22	-1.08	-1.41	-1.31	-1.24	-1.33	-1.14
Non-Cash Adjustments To Reconcile Net Income	11	13	16	18	16	13	17	15	16	22	20
Changes in Operating Assets and Liabilities, net	-20	-22	-21	-13	-20	5.47	-5.73	11	0.02	7.80	-0.87
Net Cash From Investing Activities	10	-6.87	-3.28	-15	57	-45	3.28	-30	-49	-34	11
Net Cash From Continuing Investing Activities	10	-6.87	-3.28	-15	57	-45	3.28	-30	-49	-34	11
Purchase of Property, Plant & Equipment	-3.39	-4.81	-4.62	-5.49	-3.78	-3.97	-3.71	-5.95	-3.24	-5.15	-4.31
Purchase of Investments	-39	-49	-55	-51	-28	-83	-36	-113	-80	-73	-37
Sale and/or Maturity of Investments	53	47	56	41	89	42	43	89	34	45	52
Net Cash From Financing Activities	6.61	4.56	10	-6.03	-28	-43	7.08	4.02	11	-0.80	-29
Net Cash From Continuing Financing Activities	6.61	4.56	10	-6.03	-28	-43	7.08	4.02	11	-0.80	-29
Repurchase of Common Equity	-	-	-1.18	-8.82	-32	-44	-3.74	-	-	-6.96	-40
Other Financing Activities, net	6.61	4.56	11	2.79	4.90	1.37	11	4.02	11	6.16	11
Effect of Exchange Rate Changes	-0.15	0.10	0.06	-	-	0.16	-	-	-	-	0.07

This table presents Calix's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	324	355	295	317	317	427	742	885	942	939
Total Current Assets	183	219	162	175	144	267	409	547	598	585
Cash & Equivalents	24	50	40	50	47	81	51	79	63	43
Short-Term Investments	50	28	-	-	0.00	53	153	163	157	254
Accounts Receivable	47	51	80	67	47	69	85	94	126	79
Inventories, net	48	45	32	50	40	52	89	149	133	103
Prepaid Expenses	9.47	11	11	7.31	9.70	11	31	63	119	106
Plant, Property, & Equipment, net	17	18	16	25	22	20	22	26	29	31
Total Noncurrent Assets	124	118	117	117	151	140	311	312	314	323
Goodwill	116	116	116	116	116	116	116	116	116	116
Noncurrent Deferred & Refundable Income Taxes	-	-	-	-	-	0.00	169	167	168	178
Other Noncurrent Operating Assets	1.14	1.99	0.76	1.20	35	24	26	28	31	30
Total Liabilities & Shareholders' Equity	324	355	295	317	317	427	742	885	942	939
Total Liabilities	88	143	150	165	163	147	174	205	223	158
Total Current Liabilities	67	121	128	144	115	101	128	165	188	131
Accounts Payable	20	24	36	40	11	13	29	41	35	20
Accrued Expenses	36	70	49	58	58	69	72	90	116	84
Current Deferred Revenue	12	28	13	16	17	19	27	34	37	27
Total Noncurrent Liabilities	21	21	22	21	47	46	45	40	35	27
Noncurrent Deferred Revenue	20	20	21	17	18	20	22	25	25	21
Other Noncurrent Operating Liabilities	1.29	0.88	1.13	3.97	29	26	23	15	10	6.30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	236	213	145	152	154	280	568	680	719	781
Total Preferred & Common Equity	236	213	145	152	154	280	568	680	719	781
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	236	213	145	152	154	280	568	680	719	781
Common Stock	820	838	852	878	897	950	999	1,072	1,080	1,172
Retained Earnings	-557	-584	-667	-685	-703	-669	-431	-390	-360	-390
Accumulated Other Comprehensive Income / (Loss)	-0.20	-0.66	-0.17	-0.75	-0.85	-0.19	-0.32	-2.47	-0.66	-0.61

This table presents Calix's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025
Total Assets	867	915	942	927	923	918	938	917
Total Current Assets	535	576	599	588	579	570	585	562
Cash & Equivalents	75	94	90	136	88	84	62	42
Short-Term Investments	160	163	174	114	151	177	225	240
Accounts Receivable	101	92	97	81	100	82	85	76
Inventories, net	141	157	153	150	120	113	101	101
Prepaid Expenses	59	70	85	107	119	113	112	103
Plant, Property, & Equipment, net	24	27	29	29	29	31	31	31
Total Noncurrent Assets	307	311	314	310	315	317	321	324
Goodwill	116	116	116	116	116	116	116	116
Noncurrent Deferred & Refundable Income Taxes	164	168	166	163	170	173	178	179
Other Noncurrent Operating Assets	27	27	31	31	29	27	27	29
Total Liabilities & Shareholders' Equity	867	915	942	927	923	918	938	917
Total Liabilities	219	197	200	176	180	164	159	150
Total Current Liabilities	181	161	162	139	146	133	130	123
Accounts Payable	66	35	35	22	19	12	24	23
Accrued Expenses	81	81	85	82	88	89	76	70
Current Deferred Revenue	34	44	42	35	39	32	30	29
Total Noncurrent Liabilities	39	36	38	37	34	31	29	27
Noncurrent Deferred Revenue	25	25	25	25	24	22	21	21
Other Noncurrent Operating Liabilities	14	11	12	11	9.58	8.60	7.55	5.82
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	648	718	742	751	743	754	779	767
Total Preferred & Common Equity	648	718	742	751	743	754	779	767
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	648	718	742	751	743	754	779	767
Common Stock	1,052	1,099	1,114	1,106	1,104	1,123	1,150	1,162
Retained Earnings	-402	-380	-371	-354	-360	-368	-372	-395
Accumulated Other Comprehensive Income / (Loss)	-3.08	-1.31	-1.59	-1.36	-0.98	-0.97	0.49	-0.35

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.55%	12.60%	11.24%	-13.53%	-3.85%	27.55%	25.53%	27.74%	19.79%	-20.02%
EBITDA Growth	-54.00%	-435.03%	-456.16%	87.33%	41.24%	1,043.08%	77.60%	-25.96%	-42.51%	-179.30%
EBIT Growth	-28.69%	-4.89%	-200.03%	77.78%	14.13%	330.31%	103.67%	-28.78%	-51.85%	-275.58%
NOPAT Growth	-30.05%	-6.07%	-190.04%	77.30%	16.81%	433.80%	574.12%	-83.54%	-45.93%	-239.55%
Net Income Growth	-26.52%	-4.06%	-203.01%	76.76%	8.31%	289.24%	611.92%	-82.80%	-28.49%	-201.44%
EPS Growth	-24.39%	-9.80%	-196.43%	77.71%	13.51%	268.75%	550.00%	-82.91%	-30.00%	-207.14%
Operating Cash Flow Growth	-114.03%	557.20%	-357.06%	105.67%	30.73%	1,004.62%	10.47%	-52.14%	106.93%	21.60%
Free Cash Flow Firm Growth	-225.88%	138.02%	-850.13%	83.57%	-66.37%	265.83%	-3.79%	-235.16%	-15.85%	60.87%
Invested Capital Growth	0.98%	-16.86%	0.25%	-2.61%	3.73%	7.30%	148.47%	20.26%	13.88%	-2.97%
Revenue Q/Q Growth	-1.60%	6.20%	1.21%	-4.83%	1.11%	10.14%	0.95%	8.51%	1.98%	-6.58%
EBITDA Q/Q Growth	-63.62%	-109.90%	-1.92%	39.88%	58.29%	92.74%	-10.64%	-4.31%	-40.17%	-30.14%
EBIT Q/Q Growth	-34.76%	-8.28%	-1.22%	28.42%	29.56%	186.79%	-12.82%	-3.95%	-50.61%	-18.70%
NOPAT Q/Q Growth	-35.06%	-9.76%	-0.65%	29.12%	30.15%	190.19%	-1.13%	-19.12%	-48.54%	-18.31%
Net Income Q/Q Growth	-33.16%	-7.61%	-1.69%	27.41%	25.56%	238.94%	-1.74%	-16.24%	-38.72%	-61.48%
EPS Q/Q Growth	-37.84%	-7.69%	-1.84%	28.85%	27.27%	285.71%	-3.31%	-15.49%	-39.13%	-66.67%
Operating Cash Flow Q/Q Growth	-123.91%	2,097.93%	-563.13%	112.31%	96.04%	138.49%	-23.92%	-19.33%	18.59%	0.65%
Free Cash Flow Firm Q/Q Growth	-603.32%	161.57%	-529.98%	68.27%	41.14%	1,553.10%	-39.73%	-101.90%	14.54%	2.40%
Invested Capital Q/Q Growth	-0.31%	-14.22%	23.35%	8.77%	3.26%	2.41%	4.95%	6.01%	-0.44%	-1.48%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.74%	43.86%	33.88%	44.73%	44.29%	49.33%	52.49%	50.17%	49.86%	54.55%
EBITDA Margin	0.93%	-2.77%	-13.84%	-2.03%	-1.24%	9.16%	12.96%	7.51%	3.61%	-3.57%
Operating Margin	-6.51%	-6.13%	-15.98%	-4.20%	-3.63%	6.81%	10.88%	6.06%	2.46%	-5.18%
EBIT Margin	-6.37%	-5.93%	-15.99%	-4.11%	-3.67%	6.63%	10.75%	6.00%	2.41%	-5.29%
Profit (Net Income) Margin	-6.46%	-5.97%	-16.27%	-4.37%	-4.17%	6.19%	35.09%	4.73%	2.82%	-3.58%
Tax Burden Percent	102.07%	101.28%	101.52%	102.82%	107.03%	97.67%	328.10%	75.89%	84.37%	94.00%
Interest Burden Percent	99.46%	99.44%	100.20%	103.48%	106.15%	95.58%	99.45%	103.86%	138.73%	71.94%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	2.33%	-228.10%	24.11%	15.63%	0.00%
Return on Invested Capital (ROIC)	-11.50%	-13.25%	-42.28%	-9.71%	-8.04%	25.42%	95.02%	9.96%	4.61%	-6.13%
ROIC Less NNEP Spread (ROIC-NNEP)	-3.12%	-3.08%	16.76%	32.47%	28.61%	28.73%	97.51%	9.47%	1.26%	-6.28%
Return on Net Nonoperating Assets (RNNOA)	1.14%	1.04%	-4.11%	-3.29%	-3.53%	-10.00%	-38.85%	-3.38%	-0.42%	2.17%
Return on Equity (ROE)	-10.36%	-12.21%	-46.40%	-13.00%	-11.57%	15.42%	56.17%	6.57%	4.19%	-3.97%
Cash Return on Invested Capital (CROIC)	-12.47%	5.15%	-42.53%	-7.07%	-11.70%	18.38%	9.81%	-8.44%	-8.37%	-3.12%
Operating Return on Assets (OROA)	-7.47%	-8.01%	-25.10%	-5.93%	-4.91%	9.64%	12.49%	6.40%	2.74%	-4.68%
Return on Assets (ROA)	-7.59%	-8.07%	-25.53%	-6.31%	-5.58%	9.00%	40.77%	5.04%	3.21%	-3.16%
Return on Common Equity (ROCE)	-10.36%	-12.21%	-46.40%	-13.00%	-11.57%	15.42%	56.17%	6.57%	4.19%	-3.97%
Return on Equity Simple (ROE_SIMPLE)	-11.17%	-12.87%	-57.28%	-12.70%	-11.49%	11.94%	41.94%	6.03%	4.08%	-3.81%
Net Operating Profit after Tax (NOPAT)	-19	-20	-57	-13	-11	36	243	40	22	-30
NOPAT Margin	-4.55%	-4.29%	-11.19%	-2.94%	-2.54%	6.65%	35.71%	4.60%	2.08%	-3.62%
Net Nonoperating Expense Percent (NNEP)	-8.38%	-10.18%	-59.04%	-42.19%	-36.65%	-3.31%	-2.49%	0.49%	3.35%	0.15%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	5.87%	3.00%	-3.86%
Cost of Revenue to Revenue	53.26%	56.14%	66.12%	55.27%	55.71%	50.67%	47.51%	49.83%	50.14%	45.45%
SG&A Expenses to Revenue	9.44%	9.07%	7.81%	9.18%	8.75%	8.21%	8.21%	8.79%	9.66%	11.89%
R&D to Revenue	22.02%	23.29%	24.99%	20.39%	19.13%	15.75%	14.98%	15.21%	17.10%	21.63%
Operating Expenses to Revenue	53.24%	49.99%	49.86%	48.92%	47.92%	42.53%	41.60%	44.11%	47.40%	59.73%
Earnings before Interest and Taxes (EBIT)	-26	-27	-82	-18	-16	36	73	52	25	-44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3.79	-13	-71	-8.95	-5.26	50	88	65	37	-30
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.70	1.76	2.07	3.41	2.88	6.56	8.97	6.59	4.00	2.96
Price to Tangible Book Value (P/TBV)	3.54	3.88	10.42	14.49	11.73	11.20	11.27	7.95	4.77	3.48
Price to Revenue (P/Rev)	0.98	0.82	0.59	1.17	1.05	3.40	7.50	5.16	2.77	2.78
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	54.90	21.39	109.20	98.13	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	1.82%	4.68%	0.92%	1.02%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.01	2.21	2.15	3.78	3.12	11.63	13.44	9.68	5.33	4.17
Enterprise Value to Revenue (EV/Rev)	0.80	0.65	0.57	1.13	1.01	3.15	7.20	4.88	2.56	2.42
Enterprise Value to EBITDA (EV/EBITDA)	86.07	0.00	0.00	0.00	0.00	34.38	55.57	64.97	70.89	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	47.52	66.99	81.42	106.07	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	47.37	20.17	106.11	123.10	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	12.19	0.00	139.82	91.63	33.16	86.18	155.85	47.24	29.46
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	38.87	0.00	0.00	0.00	65.51	195.51	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.21	0.20	0.19	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.37	-0.34	-0.25	-0.10	-0.12	-0.35	-0.40	-0.36	-0.33	-0.35
Leverage Ratio	1.37	1.51	1.82	2.06	2.07	1.71	1.38	1.30	1.31	1.25
Compound Leverage Factor	1.36	1.51	1.82	2.13	2.20	1.64	1.37	1.35	1.81	0.90
Debt to Total Capital	0.00%	0.00%	17.15%	16.49%	16.30%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	17.15%	16.49%	16.30%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	82.85%	83.51%	83.70%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	-0.42	-3.35	-5.71	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.14	2.27	3.32	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	-0.53	-2.31	-2.78	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.17	1.56	1.62	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	1.74	0.65	-1.01	0.18	-0.18	7.32	18.50	14.17	8.93	9.49
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.72	1.81	1.27	1.22	1.25	2.64	3.19	3.31	3.19	4.46
Quick Ratio	1.80	1.07	0.94	0.81	0.81	2.01	2.26	2.03	1.85	2.87
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-20	7.65	-57	-9.43	-16	26	25	-34	-39	-15
Operating Cash Flow to CapEx	-73.39%	248.19%	-782.11%	34.15%	34.85%	657.49%	542.80%	193.24%	315.04%	378.86%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.17	1.35	1.57	1.44	1.34	1.45	1.16	1.07	1.14	0.88
Accounts Receivable Turnover	10.46	9.32	7.75	5.99	7.47	9.34	8.79	9.70	9.46	8.10
Inventory Turnover	4.60	5.59	8.87	5.97	5.24	5.93	4.57	3.63	3.70	3.21
Fixed Asset Turnover	21.85	26.12	30.32	21.73	18.26	25.83	32.23	36.45	37.60	27.44
Accounts Payable Turnover	10.04	11.86	11.29	6.40	9.27	22.94	15.31	12.27	13.69	13.75
Days Sales Outstanding (DSO)	34.89	39.18	47.10	60.96	48.83	39.09	41.54	37.65	38.59	45.07
Days Inventory Outstanding (DIO)	79.40	65.34	41.14	61.11	69.71	61.51	79.80	100.47	98.78	113.83
Days Payable Outstanding (DPO)	36.35	30.77	32.34	57.00	39.37	15.91	23.84	29.74	26.66	26.55
Cash Conversion Cycle (CCC)	77.93	73.74	55.90	65.07	79.17	84.69	97.49	108.37	110.71	132.35
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	162	135	135	132	137	147	364	438	499	484
Invested Capital Turnover	2.52	3.09	3.78	3.31	3.16	3.82	2.66	2.16	2.22	1.69
Increase / (Decrease) in Invested Capital	1.58	-27	0.33	-3.53	4.91	9.97	218	74	61	-15
Enterprise Value (EV)	326	298	290	498	426	1,705	4,894	4,236	2,657	2,015
Market Capitalization	400	376	300	518	444	1,838	5,099	4,478	2,878	2,312
Book Value per Share	$4.64	$4.37	$2.88	$2.86	$2.78	$4.54	$8.92	$10.38	$10.92	$11.78
Tangible Book Value per Share	$2.22	$1.98	$0.57	$0.67	$0.68	$2.66	$7.09	$8.61	$9.15	$10.02
Total Capital	236	213	175	182	184	280	568	680	719	781
Total Debt	0.00	0.00	30	30	30	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-74	-78	-9.78	-20	-17	-134	-204	-242	-220	-297
Capital Expenditures (CapEx)	7.28	9.84	8.03	10	13	7.82	10	14	18	18
Debt-free, Cash-free Net Working Capital (DFCFNWC)	42	20	24	11	11	32	77	140	190	157
Debt-free Net Working Capital (DFNWC)	116	98	64	61	58	166	281	382	410	454
Net Working Capital (NWC)	116	98	34	31	28	166	281	382	410	454
Net Nonoperating Expense (NNE)	7.78	7.72	26	6.34	6.91	2.50	4.21	-1.09	-7.74	-0.38
Net Nonoperating Obligations (NNO)	-74	-78	-9.78	-20	-17	-134	-204	-242	-220	-297
Total Depreciation and Amortization (D&A)	30	15	11	9.19	10	14	15	13	12	14
Debt-free, Cash-free Net Working Capital to Revenue	10.30%	4.32%	4.77%	2.45%	2.56%	5.92%	11.30%	16.16%	18.27%	18.82%
Debt-free Net Working Capital to Revenue	28.36%	21.34%	12.56%	13.84%	13.75%	30.64%	41.38%	44.01%	39.47%	54.55%
Net Working Capital to Revenue	28.36%	21.34%	6.69%	7.04%	6.68%	30.64%	41.38%	44.01%	39.47%	54.55%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.51)	($0.56)	($1.66)	($0.37)	($0.32)	$0.57	$3.77	$0.63	$0.44	($0.45)
Adjusted Weighted Average Basic Shares Outstanding	48.45M	49.59M	51.71M	54.04M	56.56M	59.07M	63.28M	65.06M	65.98M	65.88M
Adjusted Diluted Earnings per Share	($0.51)	($0.56)	($1.66)	($0.37)	($0.32)	$0.54	$3.51	$0.60	$0.42	($0.45)
Adjusted Weighted Average Diluted Shares Outstanding	48.45M	49.59M	51.71M	54.04M	56.56M	62.00M	67.86M	68.91M	69.32M	65.88M
Adjusted Basic & Diluted Earnings per Share	($0.51)	($0.56)	($1.66)	($0.37)	($0.32)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	51.49M	48.73M	50.16M	52.61M	54.99M	62.45M	64.44M	66.14M	65.41M	66.69M
Normalized Net Operating Profit after Tax (NOPAT)	-19	-23	-54	-14	-11	42	51	40	22	-30
Normalized NOPAT Margin	-4.55%	-4.98%	-10.60%	-3.10%	-2.54%	7.78%	7.54%	4.60%	2.08%	-3.62%
Pre Tax Income Margin	-6.33%	-5.90%	-16.03%	-4.25%	-3.90%	6.33%	10.69%	6.23%	3.34%	-3.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-103.21%	-46.74%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	294.62%	-35.95%

This table displays calculated financial ratios and metrics derived from Calix's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	10/1/2022	12/31/2022	4/1/2023	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	37.22%	38.59%	35.18%	29.19%	11.64%	8.27%	-9.48%	-24.09%	-23.84%	-22.14%	-2.68%
EBITDA Growth	6.44%	-9.13%	-7.34%	13.83%	-17.66%	-155.32%	-89.88%	-152.29%	-140.47%	-78.18%	-343.43%
EBIT Growth	13.37%	-5.80%	-0.85%	26.99%	-22.07%	-193.29%	-122.18%	-197.23%	-171.51%	-56.93%	-189.66%
NOPAT Growth	-92.82%	-47.59%	2.61%	3.11%	13.27%	-176.60%	-105.35%	-202.17%	-151.24%	-55.07%	-851.83%
Net Income Growth	-92.42%	-40.01%	18.22%	24.62%	26.11%	-155.33%	-98.93%	-184.90%	-123.41%	-171.62%	-4,747.57%
EPS Growth	-92.72%	-37.93%	16.67%	18.18%	26.32%	-150.00%	-100.00%	-192.31%	-125.00%	-200.00%	0.00%
Operating Cash Flow Growth	-37.94%	-51.62%	10.14%	149.52%	134.60%	144.46%	81.10%	27.96%	1.57%	2.94%	17.16%
Free Cash Flow Firm Growth	-154.48%	68.08%	64.17%	63.88%	-37.65%	-10.43%	41.87%	69.97%	102.91%	102.40%	132.89%
Invested Capital Growth	19.06%	20.26%	21.68%	21.77%	21.26%	13.88%	9.21%	3.22%	-1.95%	-2.97%	-3.65%
Revenue Q/Q Growth	16.97%	3.46%	2.25%	4.40%	1.08%	0.34%	-14.51%	-12.45%	1.42%	2.58%	6.85%
EBITDA Q/Q Growth	71.04%	-29.27%	-19.68%	17.15%	23.72%	-147.52%	114.70%	-705.18%	4.24%	-109.21%	79.92%
EBIT Q/Q Growth	110.74%	-34.32%	-25.15%	22.57%	29.32%	-178.62%	82.20%	-437.24%	4.88%	-72.53%	67.15%
NOPAT Q/Q Growth	74.14%	-15.91%	-24.35%	-6.92%	91.31%	-156.86%	94.72%	-1,677.49%	4.05%	-72.08%	67.57%
Net Income Q/Q Growth	78.74%	-11.28%	-19.53%	-2.34%	80.87%	-138.93%	101.56%	-7,826.21%	50.14%	-351.71%	73.29%
EPS Q/Q Growth	72.73%	-5.26%	-22.22%	-7.14%	84.62%	-137.50%	100.00%	0.00%	50.00%	-350.00%	74.07%
Operating Cash Flow Q/Q Growth	-4.07%	-9.07%	32.87%	115.29%	-9.81%	-5.25%	-1.56%	52.11%	-28.41%	-3.98%	12.04%
Free Cash Flow Firm Q/Q Growth	75.35%	-18.36%	-17.61%	-5.24%	6.04%	5.05%	38.09%	45.62%	109.10%	-21.67%	748.27%
Invested Capital Q/Q Growth	5.30%	6.01%	5.24%	3.66%	4.86%	-0.44%	0.92%	-2.03%	-0.39%	-1.48%	0.21%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.17%	51.08%	51.22%	52.28%	53.27%	42.78%	54.16%	54.31%	54.76%	55.00%	55.72%
EBITDA Margin	9.52%	6.51%	5.11%	5.74%	7.02%	-3.33%	0.57%	-3.95%	-3.73%	-7.61%	-1.43%
Operating Margin	8.46%	5.34%	3.97%	4.53%	6.04%	-4.57%	-0.90%	-5.73%	-5.42%	-9.10%	-2.76%
EBIT Margin	8.41%	5.34%	3.91%	4.59%	5.87%	-4.60%	-0.96%	-5.88%	-5.51%	-9.27%	-2.85%
Profit (Net Income) Margin	5.69%	4.88%	3.84%	3.59%	6.43%	-2.49%	0.05%	-4.02%	-1.97%	-8.70%	-2.17%
Tax Burden Percent	65.68%	84.67%	84.13%	65.87%	93.44%	73.13%	22.01%	91.66%	50.92%	114.60%	160.10%
Interest Burden Percent	102.99%	107.94%	116.79%	118.83%	117.17%	74.12%	-21.60%	74.57%	70.36%	81.86%	47.63%
Effective Tax Rate	34.32%	15.33%	15.87%	34.13%	6.56%	0.00%	77.99%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	11.70%	9.78%	7.43%	6.80%	12.59%	-7.10%	-0.42%	-7.88%	-6.81%	-10.78%	-3.23%
ROIC Less NNEP Spread (ROIC-NNEP)	11.56%	9.39%	6.90%	6.15%	11.73%	-7.91%	-0.64%	-7.87%	-8.17%	-8.92%	-3.03%
Return on Net Nonoperating Assets (RNNOA)	-4.14%	-3.36%	-2.48%	-2.21%	-4.07%	2.61%	0.22%	2.77%	2.87%	3.08%	1.05%
Return on Equity (ROE)	7.57%	6.43%	4.95%	4.59%	8.52%	-4.49%	-0.20%	-5.11%	-3.94%	-7.70%	-2.18%
Cash Return on Invested Capital (CROIC)	-4.41%	-8.44%	-9.97%	-10.35%	-10.04%	-8.37%	-6.45%	-8.60%	-3.17%	-3.12%	-2.96%
Operating Return on Assets (OROA)	8.61%	5.69%	4.31%	5.25%	6.67%	-5.23%	-1.06%	-6.02%	-5.26%	-8.19%	-2.56%
Return on Assets (ROA)	5.82%	5.20%	4.24%	4.11%	7.30%	-2.84%	0.05%	-4.12%	-1.89%	-7.69%	-1.95%
Return on Common Equity (ROCE)	7.57%	6.43%	4.95%	4.59%	8.52%	-4.49%	-0.20%	-5.11%	-3.94%	-7.70%	-2.18%
Return on Equity Simple (ROE_SIMPLE)	7.56%	0.00%	5.92%	5.98%	6.37%	0.00%	2.67%	0.33%	-2.37%	0.00%	-4.51%
Net Operating Profit after Tax (NOPAT)	13	11	8.36	7.78	15	-8.46	-0.45	-7.95	-7.63	-13	-4.26
NOPAT Margin	5.56%	4.52%	3.34%	2.98%	5.64%	-3.20%	-0.20%	-4.01%	-3.80%	-6.37%	-1.93%
Net Nonoperating Expense Percent (NNEP)	0.14%	0.39%	0.53%	0.65%	0.85%	0.81%	0.22%	0.00%	1.36%	-1.85%	-0.20%
Return On Investment Capital (ROIC_SIMPLE)	-	1.63%	-	-	-	-1.18%	-	-	-	-1.68%	-0.55%
Cost of Revenue to Revenue	49.83%	48.92%	48.78%	47.72%	46.73%	57.22%	45.84%	45.69%	45.24%	45.00%	44.28%
SG&A Expenses to Revenue	8.14%	9.04%	9.23%	9.47%	9.59%	10.31%	11.62%	11.41%	11.53%	13.01%	12.15%
R&D to Revenue	14.05%	15.77%	17.27%	17.37%	17.80%	15.98%	19.63%	22.27%	22.63%	22.25%	19.97%
Operating Expenses to Revenue	41.71%	45.74%	47.24%	47.76%	47.23%	47.34%	55.06%	60.04%	60.19%	64.10%	58.48%
Earnings before Interest and Taxes (EBIT)	20	13	9.77	12	15	-12	-2.17	-12	-11	-19	-6.28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	23	16	13	15	19	-8.81	1.29	-7.83	-7.50	-16	-3.15
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	6.16	6.59	4.94	4.46	4.05	4.00	2.94	3.08	3.25	2.96	3.05
Price to Tangible Book Value (P/TBV)	7.50	7.95	5.89	5.29	4.79	4.77	3.49	3.64	3.82	3.48	3.59
Price to Revenue (P/Rev)	4.99	5.16	3.80	3.33	2.98	2.77	2.15	2.44	2.84	2.78	2.83
Price to Earnings (P/E)	81.46	109.20	83.42	74.56	63.53	98.13	110.14	928.99	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.23%	0.92%	1.20%	1.34%	1.57%	1.02%	0.91%	0.11%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	9.09	9.68	7.13	6.37	5.57	5.33	3.86	4.18	4.57	4.17	4.24
Enterprise Value to Revenue (EV/Rev)	4.69	4.88	3.52	3.07	2.74	2.56	1.91	2.16	2.52	2.42	2.49
Enterprise Value to EBITDA (EV/EBITDA)	55.09	64.97	50.63	45.87	44.53	70.89	74.81	646.48	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	69.30	81.42	62.39	55.51	55.00	106.07	148.26	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	76.05	106.11	81.68	75.35	66.51	123.10	171.52	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	111.41	155.85	117.70	79.23	58.82	47.24	30.95	30.43	33.01	29.46	28.97
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.36	-0.36	-0.36	-0.36	-0.35	-0.33	-0.34	-0.35	-0.35	-0.35	-0.35
Leverage Ratio	1.32	1.30	1.29	1.28	1.28	1.31	1.26	1.24	1.22	1.25	1.22
Compound Leverage Factor	1.36	1.41	1.51	1.52	1.50	0.97	-0.27	0.93	0.86	1.03	0.58
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	11.76	14.02	11.81	11.02	11.58	8.80	8.39	9.52	10.50	9.58	10.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.96	3.31	3.58	3.69	4.22	3.19	3.96	4.28	4.50	4.46	4.58
Quick Ratio	1.86	2.03	2.17	2.22	2.38	1.85	2.33	2.58	2.87	2.87	2.91
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-53	-63	-74	-78	-73	-69	-43	-23	2.12	1.66	14
Operating Cash Flow to CapEx	197.82%	127.00%	175.66%	318.16%	417.13%	375.73%	396.09%	375.45%	493.19%	298.37%	399.35%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.02	1.07	1.10	1.14	1.14	1.14	1.11	1.02	0.96	0.88	0.90
Accounts Receivable Turnover	8.31	9.70	10.36	10.83	11.25	9.46	10.55	10.65	10.73	8.10	9.39
Inventory Turnover	3.68	3.63	3.53	3.84	3.36	3.70	3.64	3.52	3.48	3.21	3.37
Fixed Asset Turnover	35.30	36.45	37.52	39.00	38.13	37.60	36.09	31.82	29.56	27.44	27.65
Accounts Payable Turnover	8.16	12.27	12.65	16.60	11.08	13.69	18.49	19.94	18.80	13.75	17.49
Days Sales Outstanding (DSO)	43.92	37.65	35.24	33.69	32.44	38.59	34.58	34.29	34.02	45.07	38.87
Days Inventory Outstanding (DIO)	99.18	100.47	103.49	94.94	108.57	98.78	100.24	103.84	104.76	113.83	108.31
Days Payable Outstanding (DPO)	44.75	29.74	28.86	21.99	32.96	26.66	19.74	18.31	19.41	26.55	20.86
Cash Conversion Cycle (CCC)	98.35	108.37	109.88	106.64	108.05	110.71	115.08	119.82	119.36	132.35	126.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	413	438	461	478	501	499	503	493	491	484	485
Invested Capital Turnover	2.10	2.16	2.22	2.28	2.23	2.22	2.11	1.96	1.79	1.69	1.67
Increase / (Decrease) in Invested Capital	66	74	82	85	88	61	42	15	-9.75	-15	-18
Enterprise Value (EV)	3,754	4,236	3,287	3,042	2,790	2,657	1,945	2,060	2,243	2,015	2,054
Market Capitalization	3,989	4,478	3,544	3,306	3,040	2,878	2,184	2,322	2,531	2,312	2,337
Book Value per Share	$9.93	$10.38	$10.85	$11.20	$11.32	$10.92	$11.37	$11.51	$11.83	$11.78	$11.50
Tangible Book Value per Share	$8.15	$8.61	$9.10	$9.44	$9.57	$9.15	$9.59	$9.74	$10.07	$10.02	$9.76
Total Capital	648	680	718	742	751	719	743	754	779	781	767
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-235	-242	-257	-264	-250	-220	-239	-261	-288	-297	-282
Capital Expenditures (CapEx)	3.39	4.81	4.62	5.49	3.78	3.97	3.71	5.95	3.24	5.15	4.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	120	140	158	173	198	190	193	176	168	157	157
Debt-free Net Working Capital (DFNWC)	355	382	415	437	448	410	433	437	455	454	439
Net Working Capital (NWC)	355	382	415	437	448	410	433	437	455	454	439
Net Nonoperating Expense (NNE)	-0.30	-0.88	-1.24	-1.59	-2.07	-1.86	-0.55	0.01	-3.66	4.80	0.53
Net Nonoperating Obligations (NNO)	-235	-242	-257	-264	-250	-220	-239	-261	-288	-297	-282
Total Depreciation and Amortization (D&A)	2.63	2.87	3.02	3.00	3.04	3.37	3.46	3.81	3.58	3.42	3.13
Debt-free, Cash-free Net Working Capital to Revenue	15.00%	16.16%	16.97%	17.41%	19.46%	18.27%	19.02%	18.45%	18.82%	18.82%	19.00%
Debt-free Net Working Capital to Revenue	44.35%	44.01%	44.52%	44.04%	44.00%	39.47%	42.59%	45.86%	51.13%	54.55%	53.20%
Net Working Capital to Revenue	44.35%	44.01%	44.52%	44.04%	44.00%	39.47%	42.59%	45.86%	51.13%	54.55%	53.20%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.21	$0.17	$0.15	$0.14	$0.26	($0.11)	$0.00	($0.12)	($0.06)	($0.27)	($0.07)
Adjusted Weighted Average Basic Shares Outstanding	65.36M	65.06M	66.04M	66.27M	66.29M	65.98M	65.34M	65.68M	66.08M	65.88M	66.03M
Adjusted Diluted Earnings per Share	$0.19	$0.18	$0.14	$0.13	$0.24	($0.09)	$0.00	($0.12)	($0.06)	($0.27)	($0.07)
Adjusted Weighted Average Diluted Shares Outstanding	69.17M	68.91M	69.71M	69.66M	69.58M	69.32M	68.12M	65.68M	66.08M	65.88M	66.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	65.44M	66.14M	66.24M	66.32M	65.87M	65.41M	65.53M	65.80M	66.32M	66.69M	64.82M
Normalized Net Operating Profit after Tax (NOPAT)	13	11	8.36	7.78	15	-8.46	-1.42	-7.95	-7.63	-13	-4.26
Normalized NOPAT Margin	5.56%	4.52%	3.34%	2.98%	5.64%	-3.20%	-0.63%	-4.01%	-3.80%	-6.37%	-1.93%
Pre Tax Income Margin	8.66%	5.76%	4.56%	5.45%	6.88%	-3.41%	0.21%	-4.38%	-3.88%	-7.59%	-1.36%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	2.78%	22.55%	88.63%	294.62%	448.57%	3,206.68%	-259.07%	-35.95%	-135.49%

Frequently Asked Questions About Calix's Financials

When does Calix's financial year end?

According to the most recent income statement we have on file, Calix's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Calix's net income changed over the last 9 years?

Calix's net income appears to be on an upward trend, with a most recent value of -$29.75 million in 2024, rising from -$26.33 million in 2015. The previous period was $29.33 million in 2023. See where experts think Calix is headed by visiting Calix's forecast page.

What is Calix's operating income?

Calix's total operating income in 2024 was -$43.03 million, based on the following breakdown:

Total Gross Profit: $453.59 million
Total Operating Expenses: $496.63 million

How has Calix revenue changed over the last 9 years?

Over the last 9 years, Calix's total revenue changed from $407.46 million in 2015 to $831.52 million in 2024, a change of 104.1%.

How much debt does Calix have?

Calix's total liabilities were at $158.33 million at the end of 2024, a 29.0% decrease from 2023, and a 79.7% increase since 2015.

How much cash does Calix have?

In the past 9 years, Calix's cash and equivalents has ranged from $23.63 million in 2015 to $80.81 million in 2020, and is currently $43.16 million as of their latest financial filing in 2024.

How has Calix's book value per share changed over the last 9 years?

Over the last 9 years, Calix's book value per share changed from 4.64 in 2015 to 11.78 in 2024, a change of 153.8%.

Related Companies

This page (NYSE:CALX) was last updated on 5/6/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Calix (CALX) Financials

Frequently Asked Questions About Calix's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Calix (CALX) Financials

Annual Income Statements for Calix

Quarterly Income Statements for Calix

Annual Cash Flow Statements for Calix

Quarterly Cash Flow Statements for Calix

Annual Balance Sheets for Calix

Quarterly Balance Sheets for Calix

Annual Metrics and Ratios for Calix

Quarterly Metrics and Ratios for Calix

Frequently Asked Questions About Calix's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools